Biographical sketch:

Thedieck studied in Münster (DE) and Strasbourg (FR) and received her PhD degree in 2005 at the Helmholtz Centre for Infection Research (HZI) in Braunschweig (DE). As a postdoc she worked with Michael N. Hall in Basel (CH) and became in 2008 group leader at the University of Freiburg (DE). In 2013, she joined the University of Groningen (NL) as an Adjunct Professor for metabolic signaling. In 2019, she chose to accept the chair for Biochemistry at Innsbruck University (AT). Since 2024, K. Thedieck heads the Department for Metabolism, Senescence and Autophagy at the Research Center One Health of the Ruhr Alliance and University Clinic Essen (DE). She remains affiliated with the Universities of Groningen and Freiburg.

Thedieck received numerous fellowships and prizes including awards from the German TS Foundation (2017) and the Klüh foundation (2024) for her research into new therapies for Tuberous Sclerosis Complex, and an ERC Advanced Grant. Her team pioneers systems modeling of the mTOR network in tumors and crosstalk of mTOR with RNA-protein networks, focusing on non-canonical roles of RNA-binding proteins in membrane associated mTOR signaling.

Publications